Regional Observatory on Metabolic Syndrome- LAZIO (ORSA)

AstraZeneca

Status: Completed

Conditions: Metabolic Syndrome

Study type: Observational

Funder types: Industry

Identifiers

NCT00689455

NIS-CIT-DUM-2008/2

Details and patient eligibility

About

The aim of the study, is to assess the prevalence of Metabolic Syndrome in Italy on a regional basis, defined according to NCEP/ATPIII Guidelines criteria.

Enrollment: 1,574 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• lipid profile in the last year
• Signed informed consent

Exclusion criteria

• Subjects with serious or unstable medical or psychological conditions that, in the opinion of the investigator, would compromise the subject's successful participation in the study
• Pregnancy or breast feeding
• Subject who are unwilling or unable to provide the informed consent

Trial design

1,574 participants in 1 patient group

1

Description:

Primary care population